Aspira Pathlab & Diagnostics Ltd.
No trades
No trades
Compare with Aspira Pathlab & Diagnostics Ltd.
−0.45 INR
513.00 K INR
249.82 M INR
Details
Sector
Industry
Website
Headquarters
Mumbai
Founded
1973
IPO date
Dec 5, 2017
ISIN
INE500C01017
FIGI
BBG00CSQHLY3
Identifiers
ISIN INE500C01017
Aspira Pathlab & Diagnostics Ltd. engages in the operation of diagnostic centers and laboratories. The firm involves the pathological investigations of biochemistry, hematology, histopathology, microbiology, immune-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its services include on-site and off-site evaluation of employee health; on-site industry specific fast screening tests; management of employee data ensuring complete data security and privacy; and customized packages as per industry needs. The company was founded on July 3, 1973 and is headquartered in Mumbai, India.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of ASPIRA is 99.50 INR — it has increased by 0.79% in the past 24 hours. Watch Aspira Pathlab & Diagnostics Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange Aspira Pathlab & Diagnostics Ltd. stocks are traded under the ticker ASPIRA.
ASPIRA stock has fallen by −6.92% compared to the previous week, the month change is a 12.53% rise, over the last year Aspira Pathlab & Diagnostics Ltd. has showed a 72.12% increase.
ASPIRA reached its all-time high on May 29, 2026 with the price of 135.90 INR, and its all-time low was 14.15 INR and was reached on Feb 28, 2018. View more price dynamics on ASPIRA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ASPIRA stock is 2.01% volatile and has beta coefficient of −0.88. Track Aspira Pathlab & Diagnostics Ltd. stock price on the chart and check out the list of the most volatile stocks — is Aspira Pathlab & Diagnostics Ltd. there?
Today Aspira Pathlab & Diagnostics Ltd. has the market capitalization of 1.04 B, it has increased by 10.79% over the last week.
Yes, you can track Aspira Pathlab & Diagnostics Ltd. financials in yearly and quarterly reports right on TradingView.
ASPIRA net income for the last quarter is −377.00 K INR, while the quarter before that showed −6.89 M INR of net income which accounts for 0.00% change. Track more Aspira Pathlab & Diagnostics Ltd. financial stats to get the full picture.
No, ASPIRA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Aspira Pathlab & Diagnostics Ltd. EBITDA is 9.89 M INR, and current EBITDA margin is 5.86%. See more stats in Aspira Pathlab & Diagnostics Ltd. financial statements.
Like other stocks, ASPIRA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Aspira Pathlab & Diagnostics Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Aspira Pathlab & Diagnostics Ltd. technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Aspira Pathlab & Diagnostics Ltd. stock shows the buy signal. See more of Aspira Pathlab & Diagnostics Ltd. technicals for a more comprehensive analysis.